Terms: = Pancreatic cancer AND FANCG, ENSG00000221829, 2189, O15287, XRCC9, FAG
19 results:
1. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
2. Immunological Classification of pancreatic Carcinomas to Identify Immune Index and Provide a Strategy for Patient Stratification.
Chen Y; Chen D; Wang Q; Xu Y; Huang X; Haglund F; Su H
Front Immunol; 2021; 12():719105. PubMed ID: 35111149
[TBL] [Abstract] [Full Text] [Related]
3. [Molecular predictors for the course of disease and individualized therapy in pancreatic cancer].
Damanakis AI; Gebauer F; Bruns CJ
Chirurg; 2020 Aug; 91(8):642-649. PubMed ID: 32405728
[TBL] [Abstract] [Full Text] [Related]
4. [Evaluation of postoperative complications registration status of gastric cancer by medical information: A single center feasibility study].
Wang YC; Wu ZQ; Shi JY; Li ZM; Shan F; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):729-735. PubMed ID: 31422610
[No Abstract] [Full Text] [Related]
5. A historical cohort study on glycemic-control and cancer-risk among patients with diabetes.
Dankner R; Boker LK; Boffetta P; Balicer RD; Murad H; Berlin A; Olmer L; Agai N; Freedman LS
Cancer Epidemiol; 2018 Dec; 57():104-109. PubMed ID: 30388485
[TBL] [Abstract] [Full Text] [Related]
6. The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management.
Marchegiani G; Andrianello S; Perri G; Pollini T; Caravati A; Secchettin E; Malleo G; Bassi C; Salvia R
Dig Liver Dis; 2018 Dec; 50(12):1327-1333. PubMed ID: 29941281
[TBL] [Abstract] [Full Text] [Related]
7. Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma.
Peraldo-Neia C; Ostano P; Cavalloni G; Pignochino Y; Sangiolo D; De Cecco L; Marchesi E; Ribero D; Scarpa A; De Rose AM; Giuliani A; Calise F; Raggi C; Invernizzi P; Aglietta M; Chiorino G; Leone F
BMC Genomics; 2018 Jun; 19(1):440. PubMed ID: 29871612
[TBL] [Abstract] [Full Text] [Related]
8. WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner.
Lal S; Zarei M; Chand SN; Dylgjeri E; Mambelli-Lisboa NC; Pishvaian MJ; Yeo CJ; Winter JM; Brody JR
Sci Rep; 2016 Sep; 6():33323. PubMed ID: 27616351
[TBL] [Abstract] [Full Text] [Related]
9. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.
Heetfeld M; Chougnet CN; Olsen IH; Rinke A; Borbath I; Crespo G; Barriuso J; Pavel M; O'Toole D; Walter T;
Endocr Relat Cancer; 2015 Aug; 22(4):657-64. PubMed ID: 26113608
[TBL] [Abstract] [Full Text] [Related]
10. Angiographic intervention in patients with a suspected visceral artery pseudoaneurysm complicating pancreatitis and pancreatic surgery.
Kalva SP; Yeddula K; Wicky S; Fernandez del Castillo C; Warshaw AL
Arch Surg; 2011 Jun; 146(6):647-52. PubMed ID: 21339414
[TBL] [Abstract] [Full Text] [Related]
11. Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.
Palagyi A; Neveling K; Plinninger U; Ziesch A; Targosz BS; Denk GU; Ochs S; Rizzani A; Meier D; Thasler WE; Hanenberg H; De Toni EN; Bassermann F; Schäfer C; Göke B; Schindler D; Gallmeier E
Mol Cancer; 2010 May; 9():127. PubMed ID: 20509860
[TBL] [Abstract] [Full Text] [Related]
12. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract] [Full Text] [Related]
13. Targeted disruption of FANCC and fancg in human cancer provides a preclinical model for specific therapeutic options.
Gallmeier E; Calhoun ES; Rago C; Brody JR; Cunningham SC; Hucl T; Gorospe M; Kohli M; Lengauer C; Kern SE
Gastroenterology; 2006 Jun; 130(7):2145-54. PubMed ID: 16762635
[TBL] [Abstract] [Full Text] [Related]
14. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
van der Heijden MS; Brody JR; Dezentje DA; Gallmeier E; Cunningham SC; Swartz MJ; DeMarzo AM; Offerhaus GJ; Isacoff WH; Hruban RH; Kern SE
Clin Cancer Res; 2005 Oct; 11(20):7508-15. PubMed ID: 16243825
[TBL] [Abstract] [Full Text] [Related]
15. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.
Couch FJ; Johnson MR; Rabe K; Boardman L; McWilliams R; de Andrade M; Petersen G
Cancer Res; 2005 Jan; 65(2):383-6. PubMed ID: 15695377
[TBL] [Abstract] [Full Text] [Related]
16. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
[TBL] [Abstract] [Full Text] [Related]
17. Functional screen of the fanconi anemia pathway in cancer cells by Fancd2 immunoblot.
Van Der Heijden MS; Brody JR; Kern SE
Cancer Biol Ther; 2004 Jun; 3(6):534-7. PubMed ID: 15107617
[TBL] [Abstract] [Full Text] [Related]
18. The genetics of FANCC and fancg in familial pancreatic cancer.
Rogers CD; van der Heijden MS; Brune K; Yeo CJ; Hruban RH; Kern SE; Goggins M
Cancer Biol Ther; 2004 Feb; 3(2):167-9. PubMed ID: 14726700
[TBL] [Abstract] [Full Text] [Related]
19. Fanconi anemia gene mutations in young-onset pancreatic cancer.
van der Heijden MS; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 2003 May; 63(10):2585-8. PubMed ID: 12750283
[TBL] [Abstract] [Full Text] [Related]
